Info
13F
Schedule 13D

Stempoint Capital Lp - Significant Ownership

Signature - Title: /s/ Sean C. Tan - Sean C. Tan, Authorized Signatory
Location: New York, NY
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Stempoint Capital Lp.

Significant Ownership of Stempoint Capital Lp

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
SRZN	Surrozen, Inc.	Common Stock, $0.0001 par value per share	15.8%	$5.72M	$854K	570K	+17.6%	StemPoint Capital LP	Mar 31, 2025
VTGN	Vistagen Therapeutics, Inc	Common Stock, par value $0.001 per share ("Shares")	8.2%	$5.45M		2.33M		StemPoint Capital LP	Dec 31, 2024

Showing 1 to 2 of 2 entries

Schedules 13D/G Reported by Stempoint Capital Lp:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.